Document is current
Any future updates will be listed below
-
Authors
Skarp, Sini https://orcid.org/0000-0003-2336-4221
Doedens, Anne
Holmström, Lauri
Izzi, Valerio
Saarimäki, Samu
Sliz, Eeva
Kettunen, Johannes
Pakanen, Lasse
Kerkelä, Risto
Pylkäs, Katri
Huikuri, Heikki V
Myerburg, Robert J
Junttila, Juhani
-
Funding
Funding for this research was provided by:
University of Oulu
- License Information
-
More Information
Article History
Received: 23 January 2024
Accepted: 21 May 2024
First Online: 7 June 2024
Declarations
:
: The FinGesture study protocol has been approved by the ethics committee of Oulu University Central Hospital (18.2.2013, number 2/2013). The Coordinating Ethics Committee of the Hospital District of Helsinki and Uusimaa approved the FinnGen study (protocol no. HUS/990/2017). The FinnGen study is approved by the Finnish Institute for Health and Welfare (permit nos. THL/2031/6.02.00/2017, THL/1101/5.05.00/2017, THL/341/6.02.00/2018, THL/2222/6.02.00/2018, THL/283/6.02.00/2019, THL/1721/5.05.00/2019, THL/1524/5.05.00/2020, and THL/2364/14.02/2020), digital and population data service agency (permit nos. VRK43431/2017-3, VRK/6909/2018-3, and VRK/4415/2019-3), the Social Insurance Institution (permit nos. KELA 58/522/2017, KELA 131/522/2018, KELA 70/522/2019, KELA 98/522/2019, KELA 138/522/2019, KELA 2/522/2020, and KELA 16/522/2020), and Statistics Finland (permit nos. TK-53-1041-17 and TK-53-90-20). The Biobank Access Decisions for FinnGen samples and data used in FinnGen Data Freeze 7 include THL Biobank BB2017_55, BB2017_111, BB2018_19, BB_2018_34, BB_2018_67, BB2018_71, BB2019_7, BB2019_8, BB2019_26, BB2020_1, Finnish Red Cross Blood Service Biobank 7.12.2017, Helsinki Biobank HUS/359/2017, Auria Biobank AB17-5154, Biobank Borealis of Northern Finland_2017_1013, Biobank of Eastern Finland 1186/2018, Finnish Clinical Biobank Tampere MH0004, Central Finland Biobank 1-2017, and Terveystalo Biobank STB 2018001.
: The authors declare that they have no competing interests.
